RESEARCH
Research Initiatives
"Sarcoma 0-40"
Understanding of and treatment for Sarcomas and mesenchymal tumors are major questions in cancer research and an unmet clinical need. To make a significant impact on sarcoma of children and young adults, the RTICC (Technion), joined forces with Case Comprehensive Cancer Center (CCCC) at Case Western Reserve University in Cleveland, and the Department of Pediatrics, School of Medicine at Indiana University, to establish an international multi-center consortium termed "Sarcoma 0-40".
In Collaboration with International Academic Institutions
"BRCA-MAP"
BRCA germline mutations are approximately ten times more prevalent in Israel compared to the general population. This increased prevalence provides a unique opportunity to study BRCA-associated cancers such as breast, ovarian, prostate, endometrial, and pancreatic cancers.
The RTICC (Technion) and the Broad Institute of MIT and Harvard are initiating a research consortium that will unite researchers from both institutions, as well as other partner institutions, combining Israel's unique genetic diversity and patient population with cutting-edge multi-omics and spatial technologies, as well as basic science and engineering (e.g., biology, mathematics, computer science, physics, chemistry).
The collaboration aims to create a shared platform that fosters cooperation, maximizes resources, and addresses critical questions in BRCA-related and homologous recombination (HRD)-related cancers.
In Collaboration with International Academic Institutions
